HUBERT E MD HUCKEL
CIK 1121608 · last filed 2014-10-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$84.00M
Companies
4
Total Filings
30
Lifetime Open-Market Net
$300.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CPRX | Director | 2,638,268 | $31.49 | $83.08M | $225.7K | 14 | 2014-10-06 |
| KOOL | Director | 65,000 | $14.19 | $922.1K | $284.0K | 10 | 2011-07-01 |
| TITAN PHARMACEUTICALS INC (TTP) Delisted | Director | — | $47.61 | — | $0 | 2 | 2008-06-03 |
| Valera Pharmaceuticals Inc (VLRX) Delisted | Director | 0 | — | — | -$209.0K | 2 | 2007-04-18 |
Recent Filings · Page 3 of 3
30 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-02-05 | CPRX | Buy (P) | +10,800 | $35.1K | EDGAR |
| 2008-02-01 | CPRX | Buy (P) | +10,800 | $32.9K | EDGAR |
| 2007-11-20 | KOOL | Buy (P) | +146,000 | $284.0K | EDGAR |
| 2007-09-26 | TITAN PHARMACEUTICALS INC (TTP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-07-23 | KOOL | Exer (M) | +10,000 | $18.1K | EDGAR |
| 2007-07-03 | KOOL | Grant (A) | — | $0 | EDGAR |
| 2007-04-18 | Valera Pharmaceuticals Inc (VLRX) Delisted | Disp (D) | −3,300 | $0 | EDGAR |
| 2007-03-28 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2007-02-28 | Valera Pharmaceuticals Inc (VLRX) Delisted | Mixed | — | -$133.4K | EDGAR |
| 2007-01-31 | KOOL | Exer (M) | +4,000 | $9.4K | EDGAR |
Showing 21–30 of 30
Prev
Page 3 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.